Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: SOFT-TISSUE SARCOMA, . Treffer: 18

2023

Tos, APD; Webster, F; Agaimy, A; Bovee, J; Dickson, B; Doyle, L; Dry, S; Gronchi, A; Hameed, M; Hemmings, C; Liegl-Atzwanger, B; Thway, K; Wagner, AJ; Wang, J; Yoshida, A; Fletcher, C Datasets for reporting of soft-tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
HISTOPATHOLOGY. 2023; Doi: 10.1111/his.14862
Web of Science PubMed FullText FullText_MUG

 

2022

Thomas, B; Bigdeli, AK; Nolte, S; Gazyakan, E; Harhaus, L; Bischel, O; Lehner, B; Egerer, G; Mechtersheimer, G; Hohenberger, P; Horch, RE; Andreou, D; Schmitt, J; Schuler, MK; Eichler, M; Kneser, U The Therapeutic Role of Plastic and Reconstructive Surgery in the Interdisciplinary Treatment of Soft-Tissue Sarcomas in Germany-Cross-Sectional Results of a Prospective Nationwide Observational Study (PROSa).
Cancers (Basel). 2022; 14(17): Doi: 10.3390/cancers14174312 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2021

Igrec, J; Fuchsjäger, MH Imaging of Bone Sarcomas and Soft-Tissue Sarcomas.
Rofo. 2021; 193(10):1171-1182 Doi: 10.1055/a-1401-0215
Web of Science PubMed FullText FullText_MUG

 

Scheipl, S; Barnard, M; Lohberger, B; Zettl, R; Brcic, I; Liegl-Atzwanger, B; Rinner, B; Meindl, C; Fröhlich, E Drug combination screening as a translational approach toward an improved drug therapy for chordoma.
Cell Oncol (Dordr). 2021; 44(6):1231-1242 Doi: 10.1007/s13402-021-00632-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne^® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schoffer, O; Roessler, M; Datzmann, T; Andreou, D; Jakob, J; Eichler, M; Richter, S; Schuler, MK; Schmitt, J Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data.
Oncol Res Treat. 2021; 44(3):103-110 Doi: 10.1159/000513178
Web of Science PubMed FullText FullText_MUG

 

2019

Henrichs, MP; Liem, D; Gosheger, G; Streitbuerger, A; Nottrott, M; Andreou, D; Hardes, J Megaprosthetic replacement of the distal humerus: still a challenge in limb salvage.
J Shoulder Elbow Surg. 2019; 28(5): 908-914. Doi: 10.1016/j.jse.2018.11.050
Web of Science PubMed FullText FullText_MUG

 

Scheipl, S; Liegl-Atzwanger, B; Szkandera, J; Rinner, B; Viertler, C; Friesenbichler, J; Bergovec, M; Leithner, A [Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Orthopade. 2019; 48(9): 776-783. Doi: 10.1007/s00132-019-03790-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Berry, V; Basson, L; Bogart, E; Mir, O; Blay, JY; Italiano, A; Bertucci, F; Chevreau, C; Clisant-Delaine, S; Liegl-Antzager, B; Tresch-Bruneel, E; Wallet, J; Taieb, S; Decoupigny, E; Le Cesne, A; Brodowicz, T; Penel, N REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.
Cancer. 2017; 123(12):2294-2302 Doi: 10.1002/cncr.30661 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Smolle, MA; Andreou, D; Tunn, PU; Szkandera, J; Liegl-Atzwanger, B; Leithner, A Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.
EFORT Open Rev. 2017; 2(10):421-431 Doi: 10.1302/2058-5241.2.170005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Gary, T; Leithner, A; Pichler, M Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Clin Chem Lab Med. 2015; 53(3):493-497 Doi: 10.1515/cclm-2014-0486
Web of Science PubMed FullText FullText_MUG

 

2014

Lee, W; Teckie, S; Wiesner, T; Ran, L; Prieto Granada, CN; Lin, M; Zhu, S; Cao, Z; Liang, Y; Sboner, A; Tap, WD; Fletcher, JA; Huberman, KH; Qin, LX; Viale, A; Singer, S; Zheng, D; Berger, MF; Chen, Y; Antonescu, CR; Chi, P PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
Nat Genet. 2014; 46(11): 1227-1232. Doi: 10.1038/ng.3095 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144 Doi: 10.1002/jso.23458
Web of Science PubMed FullText FullText_MUG

 

2013

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Gerger, S; Zacherl, M; Renner, W; Haijun, M; Leithner, A; Gerger, A Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Cancer Epidemiol. 2013; 37(6):1003-1009 Doi: 10.1016/j.canep.2013.10.003
Web of Science PubMed FullText FullText_MUG

 

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Samonigg, H; Glehr, M; Zacherl, M; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Br J Cancer. 2013; 108(8):1677-1683 Doi: 10.1038/bjc.2013.135 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Zacherl, M; Giessauf, C; Glehr, M; Gruber, G; Maurer-Ertl, W; Schwantzer G; Liegl-Atzwagner, B; Koch, H; Leithner, A; Windhager, R Revision of inadequately treated soft-tissue sarcoma is associated with increased need for plastic or reconstructive surgery.
ACTA CHIR AUST. 2009; 41(4): 155-162. Doi: 10.1007/s10353-009-0476-7
Web of Science FullText FullText_MUG

 

2003

Jeserschek, R; Clar, H; Aigner, C; Rehak, P; Primus, B; Windhager, R Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery: a prospective, double-blind, randomised and placebo-controlled study.
J Bone Joint Surg Br. 2003; 85(2):174-177 Doi: 10.1302/0301-620X.85B2.13303 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Windhager, R; Millesi, H; Kotz, R Resection-replantation for primary malignant tumours of the arm. An alternative to fore-quarter amputation.
J Bone Joint Surg Br. 1995; 77(2):176-184 Doi: 10.1302/0301-620X.77B2.7706328 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum